Lepu Medical’s Controlling Shareholder Pledges 27.93 Million Shares for Debt Repayment, Cumulative Pledge Ratio Rises to 39.87%

Image source: Lepu Medical "Announcement on Partial Pledge and Release of Pledge of Controlling Shareholder's Equity"

DentalGoodNews｜On July 6, 2026, Lepu Medical Technology (Beijing) Co., Ltd. (hereinafter referred to as "Lepu Medical") issued an announcement stating that its controlling shareholder, Pu Zhongjie, recently conducted partial share pledges and releases. The number of shares pledged this time is 27,930,000, accounting for 6.13% of his total holdings, with the purpose of debt repayment.

The announcement disclosed that on July 2, 2026, Pu Zhongjie newly pledged 27,930,000 shares of executive locked-up stock to Guotai Haitong Securities Co., Ltd., with the pledge starting on July 2, 2026, and an indefinite maturity date, for debt repayment. On July 3, Pu Zhongjie released pledges of 8,630,000 shares and 3,300,000 shares respectively, totaling 11,930,000 shares released, accounting for 0.65% of the company's total share capital.

Image source: Lepu Medical "Announcement on Partial Pledge and Release of Pledge of Controlling Shareholder's Equity"

As of the disclosure date, Pu Zhongjie and his concerted parties collectively hold 455,643,349 shares of Lepu Medical, accounting for 24.72% of the company's total share capital. Among these, a cumulative total of 181,669,996 shares are in a pledged state, representing 9.86% of the company's total share capital and 39.87% of their total holdings. Lepu Medical stated that the currently pledged shares have not reached the margin call line, there is no margin call risk, and the equity pledge does not affect the company's actual control.

Image source: Lepu Medical 2025 Annual Report

Public information shows that Lepu Medical's business covers multiple sectors including cardiovascular interventional and implant, surgical anesthesia, medical aesthetics, and Oral/Dental. In recent years, it has deeply participated in the Dental orthodontics market through its brand Bosimi. According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), Lepu Medical achieved operating revenue of 6.483 billion yuan in 2025, a year-on-year increase of 6.22%, with Net Profit Attributable to Shareholders of the Parent Company reaching 962 million yuan, up 289.57% year-on-year. In 2024, affected by policies such as VBP, the company's revenue declined, and it recorded a cumulative goodwill impairment of over 70% for its controlled orthodontic enterprise, Suzhou Bosimi. As of the end of 2025, the company's goodwill book balance was 3.879 billion yuan, with a goodwill impairment provision balance of 259 million yuan. The recoverable amount of the Suzhou Bosimi asset group exceeded its book value, and the annual report did not show any new goodwill impairment.

Lepu Medical stated that it will continue to monitor the share pledge situation of its shareholders and strictly comply with relevant regulations to fulfill information disclosure obligations in a timely manner.